Articles
30.11.2022
Reflecting on the Pricing & Market Access tre...

Our experts reflect on the trends that shaped the European pricing and market access landscape in 20...

Read more
Newsletter
16.11.2022
PMA Insights: Week 46 SPECIAL EDITION ISPOR 2022 R...

We summarise the ISPOR Europe 2022 conference including plenary sessions on HTA, patient-centered re...

Read more
Articles
21.09.2022
Pricing and reimbursement of cell and gene therapi...

Introduction The European landscape has seen both approvals and withdrawals of cell and gene therapi...

Read more
Articles
21.09.2022
Are payers willing to pay for innovation for gene ...

Introduction Gene and CAR-T cell therapies are often heralded as the future of healthcare, where gro...

Read more
Articles
10.08.2022
Hiya, US: What are the proposed changes to CAR-T r...

Our Market Access Analysts discuss the proposed changes to CAR-T reimbursement in the US and conside...

Read more
Articles
07.12.2021
What are the 5 Pricing & Market Access trends...

Our experts provide an overview of the five key trends that could shape the pricing and market acces...

Read more
Articles
03.12.2021
Reflecting on the Pricing & Market Access tre...

Our experts reflect on the pricing and market access trends that shaped the European Landscape in 20...

Read more
Articles
04.12.2020
What are the 5 Pricing and Market Access trends th...

Our experts predict the 5 trends they think will dominate the European pricing and market access lan...

Read more

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.